Subscribe To
in8bio to present new positive data from phase 1 trial of inb-100 at 2023 american society of hematology (ash) annual meeting
New data on the completed dose-escalation of this Phase 1 trial highlights promising efficacy of INB-100 in patients with hematologic malignancies; up...
November 2, 2023, 1:17 pm
in8bio to present new positive data from phase 1 trial of inb-100 at 2023 american society of hematology (ash) annual meeting
NEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) -- in8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceut...
November 2, 2023, 9:17 am
in8bio, inc. (inab)'s technical outlook is bright after key golden cross
in8bio, Inc. (INAB) reached a significant support level, and could be a good pick for investors from a ...
June 5, 2023, 11:10 am
in8bio, inc. (inab) is up 37.87% in one week: what you should know
Does in8bio, Inc. (INAB) have what it takes to be a top stock pick for momentum investors? Let's find o...
May 24, 2023, 1:13 pm
in8bio announces new preclinical data in ovarian cancer to be presented at asgct 26th annual meeting
Preclinical data demonstrates that gamma-delta T cells have the ability to target other solid tumors such as ovarian cancer, supporting the developmen...
May 2, 2023, 9:08 pm
Why is in8bio (inab) stock up 9% today?
in8bio (NASDAQ: INAB ) stock is rising higher on Wednesday as the company's shares continue their wild ...
April 26, 2023, 8:30 am
in8bio stock price falls even as company receives fda orphan drug status for brain cancer treatment
in8bio (NASDAQ:INAB), Inc shares slid 16% to $2.51 in early Tuesday trading after the biopharmaceutical...
April 25, 2023, 10:40 am
What is going on with in8bio (inab) stock today?
in8bio (NASDAQ: INAB ) stock is on the move Tuesday as investors react to a recent rally and additional...
April 25, 2023, 9:36 am
in8bio to present new positive clinical data from phase 1 trial of inb-100 at ebmt 2023 annual meeting
NEW YORK, April 11, 2023 (GLOBE NEWSWIRE) -- in8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceu...
April 11, 2023, 8:00 am
in8bio to present at the h.c. wainwright cell therapy virtual conference
NEW YORK, Feb. 21, 2023 (GLOBE NEWSWIRE) -- in8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceut...
February 21, 2023, 7:00 am
in8bio to present positive early data from ongoing phase 1 study of inb-100 at the 64th american society of hematology annual meeting
NEW YORK, Nov. 03, 2022 (GLOBE NEWSWIRE) -- in8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceut...
November 3, 2022, 9:10 am
11 insiders tip more capital into in8bio and broker hc wainwright initiates with bullish $14 target
Clinical stage biopharmaceutical company in8bio Inc (US:INAB) topped the Fintel Significant Insider Bu...
September 6, 2022, 10:20 pm
Helix biopharma corp names dr gabrielle siegers as its head of research and development
Helix BioPharma Corp. (TSX:HBP) has announced the appointment of Dr Gabrielle Siegers as its head of research and development based out of the company...
September 2, 2022, 6:39 am
in8bio to present at july investor and scientific conferences
NEW YORK, June 30, 2022 (GLOBE NEWSWIRE) -- in8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceut...
June 30, 2022, 4:15 pm
in8bio to present at bio ceo & investor conference and next generation car-tcr summit
NEW YORK, Feb. 10, 2022 (GLOBE NEWSWIRE) -- in8bio, Inc. (Nasdaq: INAB), a clinical-stage gamma-delta T...
February 10, 2022, 5:36 pm
in8bio to present at bio ceo & investor conference and next generation car-tcr summit
NEW YORK, Feb. 10, 2022 (GLOBE NEWSWIRE) -- in8bio, Inc. (Nasdaq: INAB), a clinical-stage gamma-delta T...
February 10, 2022, 5:36 pm
in8bio to present at bio ceo & investor conference and next generation car-tcr summit
NEW YORK, Feb. 10, 2022 (GLOBE NEWSWIRE) -- in8bio, Inc. (Nasdaq: INAB), a clinical-stage gamma-delta T...
February 10, 2022, 5:36 pm
in8bio stock jumps after an update from leukemia trial
in8bio Inc (NASDAQ: INAB) has provided an update on the Phase 1 clinical trial of INB-100, a donor-d...
December 16, 2021, 1:06 pm
in8bio stock jumps after an update from leukemia trial
in8bio Inc (NASDAQ: INAB) has provided an update on the Phase 1 clinical trial of INB-100, a donor-d...
December 16, 2021, 1:06 pm
in8bio stock jumps after an update from leukemia trial
in8bio Inc (NASDAQ: INAB) has provided an update on the Phase 1 clinical trial of INB-100, a donor-d...
December 16, 2021, 1:06 pm